Mobinitinib for myelodysplastic syndromes

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Oct 2020: Trial registered, NCT04581512
  2. 2 Nov 2020: Trial started, NCT04581512

The trials

NCT04581512: Study to Evaluate the Safety and Tolerability of EP0042

State
Under way
Phase
Phase 1 and Phase 2
People
70 planned
Started
2 Nov 2020
Primary completion
Dec 2027
Arms
Module 1 EP0042
Results
None posted
  1. 9 Oct 2020: Trial registered
  2. 2 Nov 2020: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.